The global renal denervation market revenue is expected to expand at a lucrative CAGR over the forecast period.
Renal denervation is also known as renal sympathetic denervation. Renal denervation is a type of minimally invasive procedure which involves endovascular access from femoral artery using catheter-mounted device into the renal artery. A major factor expected to drive growth of the target market over the forecast period is the growing geriatric population coupled with rising prevalence of hypertension.
The global renal denervation market report has been segmented on the basis of technology, and region. On the basis of technology, the target market has been segmented into radiofrequency based, ultrasound based, cryoablation, and micro-infusion based. The radiofrequency based segment is accounted for major share in terms of revenue in the target market, owing to the advantages of radiofrequency therapies such as permanent effect, reduced treatment time, and higher safety, is expected to drive revenue growth of this segment over the forecast period.
Request For The Sample Report Here: https://marketresearch.biz/report/renal-denervation-market/request-sample/
On the basis of region, the global renal denervation market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America hold for major share in terms of revenue in the target market and expected to maintain its dominance over the forecast period. This can be attributed to the increasing research and development activities in the region. The renal denervation market in Europe is expected to register significant growth in the target market over the forecast period followed by North America. Asia Pacific renal denervation market is projected to contribute a significant revenue share to the global target market over the forecast period. Increasing number of cases of drug-resistant hypertension, is anticipated to support revenue growth of renal denervation market.
Key players operating in the global renal denervation market include Medtronic plc, Cardiosonic, Inc., Kona Medical, Inc., Abbott Laboratories, Ablative Solutions, Inc., Renal Dynamics, LLC, Mercator MedSystems, Inc., ReCor Medical, Inc., Boston Scientific Corporation, and Symple Surgical, Inc.